XM does not provide services to residents of the United States of America.
B
B

Biomerieux

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Malawi Health Ministry, bioMerieux, Pfizer Form Multisectoral Collaboration On Antimicrobial Resistance

BRIEF-Malawi Health Ministry, bioMerieux, Pfizer Form Multisectoral Collaboration On Antimicrobial Resistance May 23 (Reuters) - Biomerieux SA BIOX.PA : MALAWI MINISTRY OF HEALTH, BIOMÉRIEUX, AND PFIZER FORM COUNTRY'S FIRST MULTISECTORAL COLLABORATION TO HELP ADDRESS ANTIMICROBIAL RESISTANCE Source textL https://tinyurl.com/46ayacaa Further compan
B
P

Barclays starts Biomerieux at 'overweight,' notes smoother growth among peers

BUZZ-Barclays starts Biomerieux at 'overweight,' notes smoother growth among peers ** Barclays initiates the French diagnostics specialist Biomerieux BIOX.PA with "overweight", saying that its organic growth has been "smoother" than the broader in vitro diagnostics peer group ** "The company has managed to grow revenues vs its 2021 base despite COV
B
D

Barclays cites DiaSorin's in-line top-line but 'ambitious' margins - starts at 'equal weight'

BUZZ-Barclays cites DiaSorin's in-line top-line but 'ambitious' margins - starts at 'equal weight' ** Barclays initiates coverage of DiaSorin DIAS.MI with "equal weight", seeing its top-line 9% CAGR revenue estimate for 2024-27 to be in line with the company's mid-term guidance and driven by the launch of new products ** However, the Italian diagno
B
D

Arkema, Fuller Smith & Turner, Siemens Energy

EUROPE RESEARCH ROUNDUP- Arkema, Fuller Smith & Turner, Siemens Energy May 9 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Arkema, Fuller Smith & Turner and Siemens Energy, on Thursday. HIGHLIGHTS * Arkema SA AKE.PA : HSBC raises target price to EUR 117 from EUR 107 * Bytes Technology Group Plc BYIT.L : Deutsche Bank initiates coverage with buy rating * Fuller Smith & Turner Plc FSTA.L : Deutsche Bank initiates coverage with buy
A
A
A
A
B
B
B
B
C
E
E
G
A
A
B
D
G

Dassault Systemes, Husqvarna, Swedbank

EUROPE RESEARCH ROUNDUP-Dassault Systemes, Husqvarna, Swedbank April 26 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Dassault Systemes, Husqvarna and Swedbank on Friday. HIGHLIGHTS * AstraZeneca AZN.L : Deutsche Bank raises target price to 11000p from 10500p * Dassault Systemes DAST.PA : JP Morgan cuts to neutral from overweight * Husqvarna AB HUSQb.ST : Jefferies raises to buy from hold * London Stock Exchange Group LSEG.L : RB
A
A
A
A
A
A
A
A
A
A
A
B
B
B
B
B
D
D
F
H
I
N
R
S
V
A
A
A
B
B
B
E
F
S

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.